Daiken Medical Co., Ltd. (TYO:7775)
Japan
· Delayed Price · Currency is JPY 470.00
+4.00 (0.86%)
Mar 10, 2026, 11:27 AM JST
Daiken Medical Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 2,384 | 2,995 | 2,739 | 2,516 | 2,518 | 2,170 | Upgrade
|
| Cash & Short-Term Investments | 2,384 | 2,995 | 2,739 | 2,516 | 2,518 | 2,170 | Upgrade
|
| Cash Growth | -19.85% | 9.35% | 8.86% | -0.08% | 16.04% | -8.24% | Upgrade
|
| Receivables | 2,812 | 2,471 | 2,479 | 2,530 | 2,431 | 2,587 | Upgrade
|
| Inventory | 1,461 | 1,430 | 1,438 | 1,514 | 1,544 | 1,421 | Upgrade
|
| Prepaid Expenses | - | 42 | 24 | 18 | 19 | 23 | Upgrade
|
| Other Current Assets | 174.25 | 47 | 50 | 60 | 60 | 71 | Upgrade
|
| Total Current Assets | 6,831 | 6,985 | 6,730 | 6,638 | 6,572 | 6,272 | Upgrade
|
| Property, Plant & Equipment | 4,014 | 3,931 | 3,986 | 4,070 | 4,119 | 4,225 | Upgrade
|
| Long-Term Investments | - | 68 | 70 | 65 | 53 | 67 | Upgrade
|
| Other Intangible Assets | 11.03 | 12 | 13 | 9 | 15 | 21 | Upgrade
|
| Long-Term Deferred Tax Assets | 188.66 | 183 | 205 | 230 | 160 | 166 | Upgrade
|
| Other Long-Term Assets | 66.24 | 2 | 2 | 1 | 1 | 1 | Upgrade
|
| Total Assets | 11,111 | 11,181 | 11,006 | 11,013 | 10,920 | 10,752 | Upgrade
|
| Accounts Payable | 529.66 | 1,027 | 1,066 | 1,117 | 1,004 | 957 | Upgrade
|
| Accrued Expenses | 92.63 | 69 | 65 | 70 | 70 | 179 | Upgrade
|
| Short-Term Debt | 920 | 746 | 1,114 | 1,058 | 1,019 | 1,033 | Upgrade
|
| Current Portion of Long-Term Debt | 390.04 | 480 | 389 | 659 | 597 | 704 | Upgrade
|
| Current Portion of Leases | - | 4 | 8 | 9 | 11 | 11 | Upgrade
|
| Current Income Taxes Payable | 94.1 | 484 | 671 | 428 | 427 | 259 | Upgrade
|
| Other Current Liabilities | 822.41 | 19 | 26 | 28 | 23 | 204 | Upgrade
|
| Total Current Liabilities | 2,849 | 2,829 | 3,339 | 3,369 | 3,151 | 3,347 | Upgrade
|
| Long-Term Debt | 540.9 | 818 | 623 | 1,013 | 1,280 | 1,177 | Upgrade
|
| Long-Term Leases | - | 3 | 8 | 16 | 26 | 28 | Upgrade
|
| Other Long-Term Liabilities | 25 | 16 | 14 | 19 | 18 | 18 | Upgrade
|
| Total Liabilities | 3,415 | 3,666 | 3,984 | 4,417 | 4,475 | 4,570 | Upgrade
|
| Common Stock | 495.88 | 495 | 495 | 495 | 495 | 495 | Upgrade
|
| Additional Paid-In Capital | 400.88 | 400 | 400 | 400 | 400 | 400 | Upgrade
|
| Retained Earnings | 8,594 | 8,414 | 7,920 | 7,506 | 7,368 | 7,112 | Upgrade
|
| Treasury Stock | -1,827 | -1,826 | -1,826 | -1,826 | -1,826 | -1,826 | Upgrade
|
| Comprehensive Income & Other | 31.38 | 32 | 33 | 21 | 8 | 1 | Upgrade
|
| Shareholders' Equity | 7,696 | 7,515 | 7,022 | 6,596 | 6,445 | 6,182 | Upgrade
|
| Total Liabilities & Equity | 11,111 | 11,181 | 11,006 | 11,013 | 10,920 | 10,752 | Upgrade
|
| Total Debt | 1,851 | 2,051 | 2,142 | 2,755 | 2,933 | 2,953 | Upgrade
|
| Net Cash (Debt) | 532.58 | 944 | 597 | -239 | -415 | -783 | Upgrade
|
| Net Cash Growth | -15.87% | 58.12% | - | - | - | - | Upgrade
|
| Net Cash Per Share | 18.54 | 32.86 | 20.78 | -8.32 | -14.45 | -27.26 | Upgrade
|
| Filing Date Shares Outstanding | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | Upgrade
|
| Total Common Shares Outstanding | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | 28.73 | Upgrade
|
| Working Capital | 3,982 | 4,156 | 3,391 | 3,269 | 3,421 | 2,925 | Upgrade
|
| Book Value Per Share | 267.89 | 261.59 | 244.43 | 229.60 | 224.34 | 215.19 | Upgrade
|
| Tangible Book Value | 7,685 | 7,503 | 7,009 | 6,587 | 6,430 | 6,161 | Upgrade
|
| Tangible Book Value Per Share | 267.50 | 261.17 | 243.97 | 229.29 | 223.82 | 214.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.